✦ LIBER ✦

Long term ursodeoxycholic acid (URSO) treatment improves glutathione status in primary biliary cirrhosis (PBC)

✍ Scribed by Philip Pemberton; Ali Aboutwerat; Alexander Smith; Sanjiv Jain; Ian Laing; Edward Mather; Thomas Warnes

Book ID: 118565478
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 229 KB
Volume: 36
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(02)80562-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary biliary cirrhosis in elderly. Lo

Primary biliary cirrhosis in elderly. Long-term treatment with ursodeoxycholic acid (UDCA)

✍ R. Giner; O. Gonzalez; JJ Terradez; JV Ballester; M. Bixquert; R. Gil; J. Alegre 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Long-term ursodeoxycholic acid delays hi

Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis

✍ Paul Angulo; Kenneth P. Batts; Terry M. Therneau; Roberta A. Jorgensen; E. Rolla 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 1 views

Primary biliary cirrhosis (PBC) is a progressive cholestatic liver disease frequently leading to development of cirrhosis and its complications. Ursodeoxycholic acid (UDCA) is a beneficial medical therapy for patients with PBC. Improvement in some histological features, but not in histological stage

Biochemical response to ursodeoxycholic

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

✍ Christophe Corpechot; Ludovico Abenavoli; Nabila Rabahi; Yves Chrétien; Tony And 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

Biochemical response to ursodeoxycholic acid (UDCA) in patients with primary biliary cirrhosis (PBC) is variable. It has been recently proposed that an alkaline phosphatase (ALP) decline of more than 40% in baseline value or a normal level after 1 year of UDCA treatment (Barcelona criteria) could se

Soluble ICAM-1 in primary biliary cirrho

Soluble ICAM-1 in primary biliary cirrhosis (PBC) during combined treatment with ursodeoxycholic acid, prednisone and azathioprine

✍ F.H.J. Wolfhagen; A.G. Lim; A. Verma; H.R. von Buuren; R.P. Jazrawi; T.C. Northf 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Comment on biochemical response to ursod

Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

✍ Lucy J. Walker; Julia Newton; David E. J. Jones; Margaret F. Bassendine 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

We read with interest the article by Corpechot et al. in a recent issue of HEPATOLOGY. 1 Corpechot et al. identify the absence of a biochemical response to ursodeoxycholic acid (UDCA) as an important predictive factor for death or liver transplantation in patients with primary biliary cirrhosis (PBC

Long-term survival and impact of ursodeo

Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation

✍ Phunchai Charatcharoenwitthaya; Sylvania Pimentel; Jayant A. Talwalkar; Felicity 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 2 views

The recurrence of primary biliary cirrhosis (PBC) in the hepatic allograft may impact patient and graft survival with long-term follow-up. The efficacy of ursodeoxycholic acid (UDCA) for treatment of recurrent PBC after liver transplantation (LT) remains less well known. The aims of this study were